C
Copeptin
Novel & Emerging BiomarkersLab test / biomarkerriskpartially modifiable
12
evidence score
PREVENT status
Not a PREVENT input variable.
Causal support
trial evidence
Score components
lit volume: 6meta-analyses: 0trials: 6genetic: 0MR bonus:
References (3)
0 meta-analyses / systematic reviews- Cardiovascular Biomarkers: Tools for Precision Diagnosis and Prognosis. — International journal of molecular sciences 2025 · PMID 40244022
- Novel biomarkers of cardiovascular disease: Applications in clinical practice — Critical Reviews in Clinical Laboratory Sciences 2018 · PMID 30457415
- Novel biomarkers for cardiovascular risk prediction. — PubMed 2017 · PMID 28491088
Clinical trials (3)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT05902117 | Place of Copeptin-troponin Assay in the Elimination Diagnosis of Non-ST+ ACS in the Management of Pre-hospital and In-hospital Non-traumatic Chest Pain in Adults | COMPLETED | INTERVENTIONAL | Troponin and Copeptin assay |
| NCT00878813 | Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk-study | COMPLETED | OBSERVATIONAL | Sampling of 15ml blood, Blood-Sampling |
| NCT00390962 | Copeptin as a Novel Diagnostic and Prognostic Marker in the Management of Neurological and Neurosurgical Patients With Sodium Imbalance The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment) | COMPLETED | OBSERVATIONAL |
Genetic associations (0)
None linked.